Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior.

Vardy E, Robinson JE, Li C, Olsen RH, DiBerto JF, Giguere PM, Sassano FM, Huang XP, Zhu H, Urban DJ, White KL, Rittiner JE, Crowley NA, Pleil KE, Mazzone CM, Mosier PD, Song J, Kash TL, Malanga CJ, Krashes MJ, Roth BL.

Neuron. 2015 May 20;86(4):936-46. doi: 10.1016/j.neuron.2015.03.065.

2.

Unilateral abducens nerve palsy in a child with rapidly increasing head circumference.

Pudukadan C, Shankar P, White C, Gertsch KR, Elton SW, Malanga CJ.

Neurology. 2015 Apr 21;84(16):1719. doi: 10.1212/WNL.0000000000001503. No abstract available.

3.

Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism.

Robinson JE, Vardy E, DiBerto JF, Chefer VI, White KL, Fish EW, Chen M, Gigante E, Krouse MC, Sun H, Thorsell A, Roth BL, Heilig M, Malanga CJ.

Neuropsychopharmacology. 2015 Oct;40(11):2614-22. doi: 10.1038/npp.2015.109.

4.

A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice.

Bilbao A, Robinson JE, Heilig M, Malanga CJ, Spanagel R, Sommer WH, Thorsell A.

Biol Psychiatry. 2015 May 15;77(10):850-8. doi: 10.1016/j.biopsych.2014.08.021.

PMID:
25442002
5.

The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo.

White KL, Robinson JE, Zhu H, DiBerto JF, Polepally PR, Zjawiony JK, Nichols DE, Malanga CJ, Roth BL.

J Pharmacol Exp Ther. 2015 Jan;352(1):98-109. doi: 10.1124/jpet.114.216820.

6.

Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice.

Fish EW, DiBerto JF, Krouse MC, Robinson JE, Malanga CJ.

J Pharmacol Exp Ther. 2014 Aug;350(2):322-9. doi: 10.1124/jpet.114.216135.

7.

Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice.

Fish EW, Whitman BJ, DiBerto JF, Robinson JE, Morrow AL, Malanga CJ.

Psychopharmacology (Berl). 2014 Sep;231(17):3415-23. doi: 10.1007/s00213-014-3600-8.

8.

Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Fish EW, Agoglia AE, Krouse MC, Muller RG, Robinson JE, Malanga CJ.

Behav Pharmacol. 2014 Feb;25(1):61-70. doi: 10.1097/FBP.0000000000000019.

9.

Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome.

Fish EW, Krouse MC, Stringfield SJ, Diberto JF, Robinson JE, Malanga CJ.

PLoS One. 2013 Oct 18;8(10):e77896. doi: 10.1371/journal.pone.0077896.

10.

Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice.

Robinson JE, Chen M, Stamatakis AM, Krouse MC, Howard EC, Faccidomo S, Hodge CW, Fish EW, Malanga CJ.

Neuropsychopharmacology. 2013 Jun;38(7):1322-33. doi: 10.1038/npp.2013.30.

11.

Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.

Riday TT, Dankoski EC, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM, Philpot BD, Malanga CJ.

J Clin Invest. 2012 Dec;122(12):4544-54. doi: 10.1172/JCI61888.

12.

Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine.

Robinson JE, Agoglia AE, Fish EW, Krouse MC, Malanga CJ.

Behav Brain Res. 2012 Sep 1;234(1):76-81. doi: 10.1016/j.bbr.2012.06.012.

13.

The rewarding and locomotor-sensitizing effects of repeated cocaine administration are distinct and separable in mice.

Riday TT, Kosofsky BE, Malanga CJ.

Neuropharmacology. 2012 Mar;62(4):1858-66. doi: 10.1016/j.neuropharm.2011.12.011.

14.

Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, Malanga CJ.

Brain Res. 2012 Jan 11;1431:53-61. doi: 10.1016/j.brainres.2011.11.003.

15.

Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine.

Fish EW, Robinson JE, Krouse MC, Hodge CW, Reed C, Phillips TJ, Malanga CJ.

Psychopharmacology (Berl). 2012 Apr;220(4):719-30. doi: 10.1007/s00213-011-2523-x.

16.

Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.

Robinson JE, Fish EW, Krouse MC, Thorsell A, Heilig M, Malanga CJ.

Psychopharmacology (Berl). 2012 Mar;220(1):215-24. doi: 10.1007/s00213-011-2469-z.

17.

Definition and classification of hyperkinetic movements in childhood.

Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, Singer HS, Alter K, Ben-Pazi H, Butler EE, Chen R, Collins A, Dayanidhi S, Forssberg H, Fowler E, Gilbert DL, Gorman SL, Gormley ME Jr, Jinnah HA, Kornblau B, Krosschell KJ, Lehman RK, MacKinnon C, Malanga CJ, Mesterman R, Michaels MB, Pearson TS, Rose J, Russman BS, Sternad D, Swoboda KJ, Valero-Cuevas F.

Mov Disord. 2010 Aug 15;25(11):1538-49. doi: 10.1002/mds.23088. Review.

18.

Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.

Timmermann L, Pauls KA, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, Revilla FJ, Santens P, Schnitzler A, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Peker S.

Brain. 2010 Mar;133(Pt 3):701-12. doi: 10.1093/brain/awq022.

19.

Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice.

Fish EW, Riday TT, McGuigan MM, Faccidomo S, Hodge CW, Malanga CJ.

Alcohol Clin Exp Res. 2010 Jan;34(1):81-9. doi: 10.1111/j.1530-0277.2009.01069.x.

PMID:
19860803
20.

Still no time for complacency: Developmental effects of prenatal methamphetamine exposure.

Malanga CJ.

Neurology. 2009 Jun 16;72(24):2062-3. doi: 10.1212/WNL.0b013e3181a92c98. No abstract available.

PMID:
19403882
Items per page

Supplemental Content

Loading ...
Support Center